CRL
Price
$342.79Alerts
Change
-$3.01 (-0.87%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
16.11B
104 days until earnings call
Intraday BUY SELL Signals
MOVE
Price
$5.70Alerts
Change
+$0.74 (+14.92%)
Updated
Nov 11 closing price
Capitalization
158.08M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

CRL vs MOVE

CRL vs MOVE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRL vs. MOVE commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and MOVE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CRL with price predictions
Nov 11, 2026

CRL sees its Stochastic Oscillator climbs out of oversold territory

On November 09, 2026, the Stochastic Oscillator for CRL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In 41 of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +12.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in 200 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 146 of 228 cases where CRL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Bearish Trend Analysis

The 10-day RSI Indicator for CRL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRL as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for CRL turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 37 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

CRL broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 1 (best 1 - 100 worst), indicating outstanding price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.674) is normal, around the industry mean (67.298). P/E Ratio (-70.170) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.122) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.340) is also within normal values, averaging (9.775).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

A.I.Advisor
a Summary for MOVE with price predictions
Nov 11, 2026

MOVE in -21.72% downward trend, falling for three consecutive days on November 06, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MOVE declined for three days, in 274 of 299 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for MOVE crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for MOVE entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MOVE's RSI Oscillator exited the oversold zone, 31 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOVE advanced for three days, in 205 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

MOVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-40.720) is normal, around the industry mean (16.272). P/E Ratio (-0.371) is within average values for comparable stocks, (52.956). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (5.110) is also within normal values, averaging (103.889).

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. MOVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
1
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRLMOVE
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CRL: $345.80 vs. MOVE: $4.96)
Brand notoriety: CRL and MOVE are both not notable
CRL represents the Medical Specialties, while MOVE is part of the Computer Communications industry
Current volume relative to the 65-day Moving Average: CRL: 68% vs. MOVE: 325%
Market capitalization -- CRL: $16.11B vs. MOVE: $158.08M
CRL [@Medical Specialties] is valued at $16.11B. MOVE’s [@Computer Communications] market capitalization is $158.08M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Computer Communications] industry ranges from $48.8K to $3.94T. The average market capitalization across the [@Medical Specialties] industry is $20.94B. The average market capitalization across the [@Computer Communications] industry is $34.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 2 FA rating(s) are green while MOVE’s FA Score has 2 green FA rating(s).

  • CRL’s FA Score: 2 green, 3 red.
  • MOVE’s FA Score: 2 green, 3 red.
According to our system of comparison, MOVE is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 3 TA indicator(s) are bullish while MOVE’s TA Score has 4 bullish TA indicator(s).

  • CRL’s TA Score: 3 bullish, 5 bearish.
  • MOVE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MOVE is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -1.73% price change this week, while MOVE (@Computer Communications) price change was -25.41% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.92%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +38.31%.

The average weekly price growth across all stocks in the @Computer Communications industry was -2.31%. For the same industry, the average monthly price growth was -11.86%, and the average quarterly price growth was -5.31%.

Reported Earning Dates

CRL is expected to report earnings on Feb 24, 2027.

MOVE is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Medical Specialties (-4.92% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Computer Communications (-2.31% weekly)

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

View a ticker or compare two or three
Interact to see
Advertisement

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-0.90%
RGEN - CRL
56%
Loosely correlated
-0.78%
AZTA - CRL
56%
Loosely correlated
+20.80%
MEDP - CRL
56%
Loosely correlated
+0.03%
BRKR - CRL
53%
Loosely correlated
+0.27%
SHC - CRL
52%
Loosely correlated
+1.04%
More

MOVE and

Correlation & Price change

A.I.dvisor tells us that MOVE and BNAI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MOVE and BNAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOVE
1D Price
Change %
MOVE100%
+14.92%
BNAI - MOVE
29%
Poorly correlated
-2.89%
CRL - MOVE
25%
Poorly correlated
-0.90%
LIVN - MOVE
25%
Poorly correlated
-0.18%
IQV - MOVE
25%
Poorly correlated
-0.23%
BFLY - MOVE
24%
Poorly correlated
+9.68%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BOTZ32.230.66
+2.09%
Global X Robotics & Artificial Intelligence ETF (BOTZ)
MUSE48.10N/A
N/A
TCW Multisector Credit Income ETF (MUSE)
KMLI8.93N/A
N/A
KraneShares 2x Long MELI Daily ETF (KMLI)
WEA9.63-0.07
-0.72%
Western Asset Premier
JRI11.71-0.12
-1.01%
NUVEEN REAL ASSET Income AND GROWTH FUND